Statistics of Le rimonabant ameliore le profit de risque cardio-metabolique chez le sujet obese ou en surpoids: synthese des etudes "RIO".

Created with Highcharts 9.2.2Number of downloadsChart context menuNumber of downloadsGenerated via ORBi - 20/05/2025
Loading...
Created with Highcharts 9.2.2Number of downloadsChart context menuNumber of downloads by countryGenerated via ORBi - 20/05/2025
Loading...
Created with Highcharts 9.2.2Number of viewsChart context menuNumber of viewsGenerated via ORBi - 20/05/2025
Loading...
Created with Highcharts 9.2.2Number of viewsChart context menuNumber of views by countryGenerated via ORBi - 20/05/2025
Loading...
Created with Highcharts 9.2.2Chart context menuOrigin of ORBi's visitorsGenerated via ORBi - 20/05/2025
Loading...
Contact ORBi